Protagonist Therapeutics (PTGX)
145.16
+0.07 (0.05%)
Upcoming Events
Latest Headlines
Protagonist Therapeutics launches $300M share repurchase program
September 8, 2026 4:05 PM - StreetInsider
Protagonist Therapeutics Announces $300 Million Share Repurchase Program
September 8, 2026 4:05 PM - StreetInsider
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
September 2, 2026 7:05 AM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $190 at BMO Capital
September 1, 2026 7:35 AM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $170 at H.C. Wainwright
September 1, 2026 7:13 AM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $180 at Barclays
September 1, 2026 4:30 AM - StreetInsider
Citi raises Protagonist Therapeutics price target to $182
September 1, 2026 4:07 AM - StreetInsider
Clear Street Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
August 31, 2026 1:05 PM - StreetInsider
Jefferies on Protagonist Therapeutics (PTGX): 'well-funded for multiple high value oral peptide pipeline'
August 31, 2026 12:31 PM - StreetInsider
Wolfe Research on Protagonist Therapeutics (PTGX): 'We forecast peak sales of $2.9B in 2036'
August 31, 2026 10:56 AM - StreetInsider
FDA approves Takeda's rusfertide for polycythemia vera treatment
August 28, 2026 8:30 PM - StreetInsider
Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
August 28, 2026 8:30 PM - StreetInsider
Protagonist Therapeutics Reports Granting of Inducement Awards
August 18, 2026 4:06 PM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $178 at BMO Capital
August 17, 2026 8:04 AM - StreetInsider
Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
August 13, 2026 5:19 PM - SEC Filing
Form 4 Protagonist Therapeutics For: Aug 10 Filed by: PATEL DINESH V PH D
August 12, 2026 6:43 PM - SEC Filing
Form 144 Protagonist Therapeutics Filed by: PATEL DINESH V PH D
August 10, 2026 4:50 PM - SEC Filing
Protagonist Therapeutics (PTGX) PT Raised to $170 at Truist Securities
August 10, 2026 7:22 AM - StreetInsider
Goldman Sachs Upgrades Protagonist Therapeutics (PTGX) to Buy
August 10, 2026 4:12 AM - StreetInsider
Form SCHEDULE 13G Protagonist Therapeutics Filed by: STATE STREET CORP
August 7, 2026 10:46 AM - SEC Filing
Protagonist Therapeutics (PTGX) PT Raised to $153 at Barclays
August 6, 2026 4:21 AM - StreetInsider
Protagonist Therapeutics (PTGX) Tops Q2 EPS by 16c
August 6, 2026 2:34 AM - StreetInsider
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:13 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:12 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:11 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:10 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:09 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:08 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:08 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:07 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:06 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:05 PM - SEC Filing
Form S-8 POS Protagonist Therapeutics
August 5, 2026 5:05 PM - SEC Filing
Form S-8 Protagonist Therapeutics
August 5, 2026 5:03 PM - SEC Filing
Form 10-Q Protagonist Therapeutics For: Jun 30
August 5, 2026 4:21 PM - SEC Filing
Form 8-K Protagonist Therapeutics For: Aug 05
August 5, 2026 4:16 PM - SEC Filing
Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 5, 2026 4:06 PM - StreetInsider
Protagonist Therapeutics Reports Granting of Inducement Awards
August 4, 2026 4:06 PM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $155 at TD Cowen
July 20, 2026 6:33 AM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $165 at Citizens as Icotyde Revenue Ramps
July 17, 2026 5:06 AM - StreetInsider
Protagonist Therapeutics Reports Granting of Inducement Awards
July 16, 2026 4:05 PM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $151 at Barclays
July 14, 2026 5:13 AM - StreetInsider
Protagonist Therapeutics (PTGX) PT Raised to $145 at Truist Securities
July 7, 2026 6:03 AM - StreetInsider
Protagonist Therapeutics Reports Granting of Inducement Awards
July 1, 2026 4:06 PM - StreetInsider
TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
July 1, 2026 9:13 AM - StreetInsider
Form 4 Protagonist Therapeutics For: Jun 23 Filed by: Waddill William D.
June 25, 2026 4:10 PM - SEC Filing
Form 144 Protagonist Therapeutics Filed by: Waddill William D.
June 23, 2026 4:27 PM - SEC Filing
Form 8-K Protagonist Therapeutics For: Jun 17
June 18, 2026 4:31 PM - SEC Filing
Protagonist Therapeutics Reports Granting of Inducement Awards
June 16, 2026 4:01 PM - StreetInsider
Full Article List
